多模态整合放射组学、病理组学与临床数据提升成人弥漫性胶质瘤分级
本研究开发并验证了融合MRI放射组学、全切片病理组学与临床变量的多模态机器学习模型,用于成人弥漫性胶质瘤分级。回顾性队列373例建模与内部验证,独立外部验证49例。多模态模型内部验证AUC为0.90,外部验证AUC为0.93,在敏感度与平衡准确率上显示临床意义的提升。
要点
- 多模态模型外部验证AUC 0.93,内部验证AUC 0.90,分级评估稳定可靠
- 多模态模型敏感度与平衡准确率高于单模态放射组学或病理组学模型
- 内部测试中多模态与放射组学(P=0.377)或病理组学(P=0.085)AUC差异无统计学意义
核心结论
- 融合放射组学、病理组学与临床信息的多模态机器学习模型对成人弥漫性胶质瘤分级评估表现出稳定可靠性能。
研究设计与样本
- 回顾性队列373例经病理确诊患者用于模型构建与内部验证,独立外部验证队列49例。
- 输入特征包括多参数MRI提取的放射组学特征、H&E染色全切片图像提取的病理组学特征,以及年龄、性别、肿瘤尺寸、解剖位置等临床变量。
- 采用随机森林、支持向量机与XGBoost三种机器学习算法构建单模态放射组学/病理组学模型及多模态整合模型。
- 经统计检验与基于随机森林的特征排序,保留40个放射组学特征和20个病理组学特征。
诊断标准与关键数值
- 最优单模态放射组学模型内部验证AUC为0.89,单模态病理组学模型内部验证AUC为0.83。
- 多模态模型内部验证AUC为0.90,外部验证AUC为0.93。
- 内部测试中多模态与放射组学模型AUC差异无统计学意义(P=0.377),与病理组学模型差异无统计学意义(P=0.085)。
临床应用与阅片要点
- 多模态模型在敏感度与平衡准确率上较单模态模型有临床意义的提升,可用于成人弥漫性胶质瘤分级辅助评估。
- 内部测试AUC差异未达统计学显著,提示多模态优势主要体现在敏感度与平衡准确率而非AUC绝对值。
局限性
- 外部验证队列仅49例,样本量较小。
- 研究为回顾性设计,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Adult diffuse gliomas exhibit marked heterogeneity, making comprehensive evaluation of their biological behavior difficult. This study aimed to develop and validate a multimodal machine learning framework that fuses MRI-based radiomic features, whole-slide image (WSI)-derived pathomic signatures, and clinical variables for the comprehensive assessment of adult diffuse gliomas.
METHODS: Radiomic features were extracted from multiparametric MRI, and pathomic features from hematoxylin-eosin (H&E) stained WSIs; both were combined with clinical variables (age, sex, tumor dimensions, anatomical location). Unimodal radiomic/pathomic models and multimodal integrated models were built using three machine learning algorithms: random forest (RF), support vector machine (SVM), and eXtreme Gradient Boosting (XGBoost).
RESULTS: A retrospective cohort of 373 pathologically confirmed patients was used for model construction and internal validation, with an independent external cohort of 49 patients for external validation. 40 radiomic and 20 pathomic features were retained via statistical testing and RF-based feature ranking. The optimal unimodal radiomic and pathomic models achieved internal validation AUCs of 0.89 and 0.83, respectively. The multimodal model showed superior performance (internal AUC = 0.90) and stable generalizability in external validation (AUC = 0.93). The multimodal model achieved AUC 0.93 with higher balanced accuracy and sensitivity. DeLong tests showed no statistically significant difference between multimodal and radiomics (P = 0.377) or pathomics (P = 0.085) in internal test; however, the multimodal model showed clinically meaningful improvements in sensitivity and balanced accuracy.
CONCLUSION: The developed and validated multimodal machine learning model integrating radiomics, pathomics, and clinical information exhibits stable and reliable performance for the grading assessment of adult diffuse gliomas.
引用
- He S, Li Z, Li J, et al. Multimodal integration of radiomics, pathomics, and clinical data enhances grading of adult diffuse gliomas using machine learning. Neuroradiology. 2026. PMID: 42154019. doi:10.1007/s00234-026-04015-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。